Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
Abstract There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of type II EC. 191 patients diagnosed with type II EC...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2021
|
| Subjects: | |
| Online Access: | https://doaj.org/article/689f3bf0919449cda19cfc08390a1656 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|